Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62018TA0502

    Case T-502/18: Judgment of the General Court of 17 September 2019 — Pharmadom v EUIPO — IRF (MediWell) (EU trade mark — Opposition proceedings — Application for EU figurative mark MediWell — Earlier national word mark WELL AND WELL and earlier national figurative mark well & well LES PHARMACIENS — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

    OJ C 399, 25.11.2019, p. 51–52 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    25.11.2019   

    EN

    Official Journal of the European Union

    C 399/51


    Judgment of the General Court of 17 September 2019 — Pharmadom v EUIPO — IRF (MediWell)

    (Case T-502/18) (1)

    (EU trade mark - Opposition proceedings - Application for EU figurative mark MediWell - Earlier national word mark WELL AND WELL and earlier national figurative mark well & well LES PHARMACIENS - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

    (2019/C 399/62)

    Language of the case: English

    Parties

    Applicant: Pharmadom (Boulogne-Billancourt, France) (represented by: M.-P. Dauquaire, lawyer)

    Defendant: European Union Intellectual Property Office (represented by: S. Bonne and H. O’Neill, acting as Agents)

    Other party to the proceedings before the Board of Appeal of EUIPO: IRF s. r. o. (Bratislava, Slovakia)

    Re:

    Action brought against the decision of the Fifth Board of Appeal of EUIPO of 8 June 2018 (Case R 6/2018-5), relating to opposition proceedings between Pharmadom and IRF.

    Operative part of the judgment

    The Court:

    1.

    Dismisses the action;

    2.

    Orders Pharmadom to pay the costs.


    (1)  OJ C 373, 15.10.2018.


    Top